<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JTR</journal-id><journal-title-group><journal-title>Journal of Tuberculosis Research</journal-title></journal-title-group><issn pub-type="epub">2329-843X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jtr.2017.51001</article-id><article-id pub-id-type="publisher-id">JTR-74002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Diagnostic Accuracy of IS6110 Insertion Gene, &lt;i&gt;Hsp65&lt;/i&gt;, and Xpert MTB/RIF for Rapid Diagnosis of Pulmonary Tuberculosis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aymen</surname><given-names>Awad Abdelhaleem</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Almonther</surname><given-names>Abdallah Hershan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pradeep</surname><given-names>Kumar Agarwal</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Endemic and Tropical Diseases Unit, Medical Research Center, Jazan University, Jazan, Saudi Arabia</addr-line></aff><aff id="aff2"><addr-line>Faculty of Medicine, Jazan University, Jazan, Saudi Arabia</addr-line></aff><aff id="aff3"><addr-line>Jazan Chest Disorders Hospital, Jazan, Saudi Arabia</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>02</month><year>2017</year></pub-date><volume>05</volume><issue>01</issue><fpage>1</fpage><lpage>12</lpage><history><date date-type="received"><day>January</day>	<month>8,</month>	<year>2017</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>February</month>	<year>5,</year>	</date><date date-type="accepted"><day>February</day>	<month>8,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Purpose: To evaluate diagnostic accuracy of 
  <em>IS6</em>110 insertion genes, 
  <em>hsp</em>65, and Xpert MTB/RIF for rapid diagnosis of pulmonary tuberculosis. 
  Methods: Sixty patients, medically reported HIV negative, clinically suspected of having pulmonary tuberculosis, were included in this study, and consented before enrolment. Sputum samples were gathered once, and tested by smear for Acid Fast Bacilli (AFB). Cultured in the Loewenstein-Jensen (LJ) medium for 
  <em>M. tuberculosis</em> growth, 
  <em>M. tuberculosis</em> DNA was detected by conventional PCR targeting IS6110, and hsp65 genes using specific primers, and automated nested real-time PCR targeting 
  <em>rpoB</em> gene. Sensitivity, specificity and diagnostic accuracy were calculated for each method compared to culture. 
  Results: Compared with culture as reference method, smear, 
  <em>IS</em>6110, 
  <em>hsp</em>65, and Xpert MTB/RIF had sensitivity 77.14%, 100%, 100%, and 100%, specificity 92%, 96%, 96%, and 96.97%, and diagnostic accuracy 83.33%, 98.33%, 98.33% and 98.21% respectively. Molecular diagnostic methods had the highest diagnostic accuracy, whereas smear had the lowest. No statistical significance, (
  <em>p</em> value &gt; 0.05) was detected between the patients’ demographic data and the presence or absence of TB infection. 
  Conclusion: The diagnostic accuracy that we got from the molecular methods, confirmed the diagnostic value of molecular detection of 
  <em>M. tuberculosis </em>in pulmonary cases, supporting the application of automated and conventional PCR in rapid analysis. Smear could be more efficient when used for treatment monitoring. Combination between one-molecular techniques with smear as a routine method could be valid for rapid diagnosis of TB.
 
</p></abstract><kwd-group><kwd>Rapid Diagnosis</kwd><kwd> Pulmonary TB</kwd><kwd> Molecular Tests</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Tuberculosis (TB) is known to be a worldwide health issue. It has been recorded to influence more than 12 million individuals every year, and the vast majority of the cases are connected with the Human Immune deficiency Virus (HIV) as TB/HIV co-infection, which builds mortality rate [<xref ref-type="bibr" rid="scirp.74002-ref1">1</xref>] . Tuberculosis is an airborne ailment brought by the bacteria known as Mycobacterium tuberculosis [<xref ref-type="bibr" rid="scirp.74002-ref1">1</xref>] .</p><p>In recent years, there is an increased TB incidence in Saudi Arabia. Several predisposing factors such as the high economic living in Saudi Arabia, attract many workers from affected areas, and also the frequent visit of pilgrims to the holy cities [<xref ref-type="bibr" rid="scirp.74002-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref4">4</xref>] .</p><p>The detection of TB bacteria in sputum smear (Acid-fast bacilli smear) still remains one of the good choices of diagnosis especially in rural areas, and low- income countries. Though, a few nations use sputum smear for treatment observing instead of analytic purpose. Culture method (the current reference standard) is used in countries with good laboratory infrastructure. Recently, the frequent use of molecular methods to diagnose tuberculosis has raised hopes for the early detection of the disease [<xref ref-type="bibr" rid="scirp.74002-ref1">1</xref>] .</p><p>Diverse gene targets like IS6110, 16S rDNA, rpoB, recA, and hsp65, which are used to distinguish M. tuberculosis gene in sputum tests, has demonstrated variability in affectability and specificity. IS6110 is a standout amongst the most well-known genes effectively used to recognize and distinguish M. tuberculosis DNA in clinical specimens by PCR [<xref ref-type="bibr" rid="scirp.74002-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref8">8</xref>] . The gene demonstrated variability in affectability and specificity as indicated by the kind of tests, of the TB restriction in the body, and nearness or nonappearance of TB/HIV co-infection [<xref ref-type="bibr" rid="scirp.74002-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.74002-ref12">12</xref>] . Likewise, the quality encoding 65-kDa heat stun protein (hsp65) has been accounted as a valuable focus for mycobacterium discovery by PCR- based methods [<xref ref-type="bibr" rid="scirp.74002-ref13">13</xref>] .</p><p>A new rapid technology such as Xpert MTB/RIF detects DNA of M. tuberculosis and rifampicin resistance gene by Real Time-PCR [<xref ref-type="bibr" rid="scirp.74002-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref15">15</xref>] . It is an automated Nucleic Acid Amplification Tests (NAAT), which isolates and detects M. tuberculosis in raw materials or sediment of sputum specimens, simultaneously. It detects most of the relevant rifampicin resistance and mutant genes. Besides, Xpert MTB/RIF required a very little technical training, and results were obtained within 90 minutes from raw sputum samples [<xref ref-type="bibr" rid="scirp.74002-ref16">16</xref>] .</p><p>In our study, we evaluated the conventional PCR targeting IS6110, and hsp65 (TB11/12) genes, and automated nested real-time PCR targeting rpoB gene to recognize M. tuberculosis DNA among suspected TB patients.</p></sec><sec id="s2"><title>2. Materials &amp; Methods</title><sec id="s2_1"><title>2.1. Ethical Approval</title><p>This study was ethically approved by the Jazan University standing committee for biomedical research ethics (SCBRE) with approval Ref No. 2198/60.</p></sec><sec id="s2_2"><title>2.2. Patients</title><p>Sixty patients who are reported HIV negative, clinically suspected of having pulmonary tuberculosis, attended to the chest diseases hospital Laboratory at the Jazan area south-west Saudi Arabia, were included in this study, were as patients whom started treatment were excluded from this study. All included patients consented before enrollment in the study.</p></sec><sec id="s2_3"><title>2.3. Samples Collection and Preparation</title><p>Sixty sputum tests were gathered, and prepared by standard research facility methods. For cleaning and processing, we took after the method portrayed by (Kent and Kubica, 1985) [<xref ref-type="bibr" rid="scirp.74002-ref17">17</xref>] . Briefly about 3 ml of sputum sample was added to an equal volume of BBL Myco Prep (cat#240862) containing NALC-NaoH with PBS in 15 ml falcon tube (BD), kept for 15 minutes for digestion, and then PBS was added till 15 ml, centrifuged at 3000/rpm 4˚C, for 15 minutes, and the supernatant was discharged and 3 ml PBS was added to the pelted sample for DNA extraction and detection assays. Smears and cultures were performed before sample deactivation. The sample deactivation as described by Doig et al. 2002 [<xref ref-type="bibr" rid="scirp.74002-ref18">18</xref>] , was done for the sample before transferring to a molecular biology lab for PCR.</p></sec><sec id="s2_4"><title>2.4. Ziehl Neelsen (ZN) Staining Method</title><p>Sputum tests were researched for the nearness of acid-fast bacilli (AFB) by Ziehl Neelsen staining method, smear arrangement and staining was done by maker’s guideline of Crescent Ref MS412, and Lot number 32706F.</p></sec><sec id="s2_5"><title>2.5. Culture</title><p>About 0.5 ml of all sputum samples was cultured in the Loewenstein-Jensen (LJ) medium. Liquid culture was not used in this study because it was not available at the time when we did the study. A negative culture was affirmed following 8 weeks of incubation, and a positive culture was affirmed by the typical growth development of M. tuberculosis trailed by AFB smear and Real-time PCR discovery. The positive control strain of Mycobacterium species was generously provided by the laboratories of the microbiology department of the faculty of medicine King Khalid University.</p></sec><sec id="s2_6"><title>2.6. DNA Extraction</title><p>DNA was extracted from sputum, and a positive culture By Promega DNA extraction kit according to the manufacturer’s instruction with minor modifications, as lyses step sputum samples and purified culture was treated with a 20ul freshly prepared lysosyme solution(Cat#L6876, Sigma, USA) at concentration 10 mg/ml. The extracted DNA was kept in −20˚C till used.</p></sec><sec id="s2_7"><title>2.7. Amplification of IS6110 Gene by PCR</title><p>A 20 &#181;L of PCR reaction was prepared by adding 1 &#181;L of 10x dNTPs (1.25 &#181;M each of dTTP, dGTP, dCTP, and dATP), 1 &#181;L of each primer (0.5 &#181;M), 4 &#181;L of 10min PCR buffer, 2 &#181;L of MgCl<sub>2</sub> (50 &#181;M), 5.8 &#181;L of sterile distilled water, 0.2 &#181;L of Taq polymerase of (5 Unit/&#181;L), and 5 &#181;L DNA sample. DNA was amplified by PCR using the following cycle conditions: 94˚C for 5 minutes, then 38 cycles: (94˚C for 1 minute, 68˚C for 1 minute). The primers of IS6110 genes were (F, 5'-CCT GCG AGC GTA GGC GTC GG-3'; R, 5' CTC GTC CAG CGC CGC TTC GG), which amplified 123 bp fragment as described by [<xref ref-type="bibr" rid="scirp.74002-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.74002-ref20">20</xref>] . The presence of a single band equivalent to 123 bp (<xref ref-type="fig" rid="fig1">Figure 1</xref>) was taken as positive results, while the same band produced by the positive control, and the negative control offered no response.</p></sec><sec id="s2_8"><title>2.8. Amplification of hsp65 by PCR</title><p>PCR master mix for hsp65 (TB11/12) gene was prepared by the same method for IS6110 genes with cycle conditions as follows: 95˚C for 4 minutes, followed by 30 cycles: (95˚C for 30 seconds, 56˚C for 1 minute, 72˚C for 40 seconds), and a final extension of 72˚C for 7 minutes. The primers of hsp65 (TB11/12) insertion gene were TB11 (5'-ACC AAC GAT GGT GTG TCC AT), and TB12 (5'-CTT GTC GAA CCG CAT ACC CT), which amplified a 440 bp fragment as described by [<xref ref-type="bibr" rid="scirp.74002-ref21">21</xref>] . The presence of a single band equivalent to 440 bp (<xref ref-type="fig" rid="fig2">Figure 2</xref>) was taken as positive results while the same band produced by the positive control, and the negative control offered no response.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Sputum samples tested by IS6110 gene, lanes1 a 50 pb Mwt marker, Lane2 negative sample, lanes 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, and 14 positive samples produced 123 pb</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1130184x2.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Sputum samples tested by hsp65 (TB11/12) gene, lanes1 negative sample, lanes 2, 3, 4, and 5 positive samples produced 440 pb, lane 6 a 100 pb marker</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1130184x3.png"/></fig></sec><sec id="s2_9"><title>2.9. Electrophoresis of Amplified Products</title><p>Amplified products were visualized on 1.8% agarose gels stained with flouro-safe dye (0.5 mg/L), and examined under UV light.</p></sec><sec id="s2_10"><title>2.10. Xpert MTB/RIF Test</title><p>This test was performed on a robotized Cephoid Gene Xpert Instrument framework (Ref GXMTB/RIF-US-10), quickly, around 0.5 ml of concentrated sputum silt was added to the Gene Xpert cartridge, that holds the Real Time-PCR and PCR reagents and host every one of the procedures. The outcomes were investigated by utilizing Gene Xpert Software adaptation 4.3. The identification of M. tuberculosis (MTB) was accounted for when no less than two tests in Ct values inside the substantial extent, and MTB not recognized was accounted for when there was only one or no positive analysis.</p></sec><sec id="s2_11"><title>2.11. Statistical Analysis</title><p>Data analysis was directed utilizing (SPSS 20.0 for Windows, SPSS inc. Chicago, IL, USA). The results of the different samples were analyzed and statistically matched. Since the investigation was led utilizing known culture-positive and-negative samples, the greater part of the samples were thought to be true positives (Tps) or true negatives (Tns). The four analyses results were named Tp, false negative (Fn), Tn, or false positive (Fp). The sensitivity and specificity were computed in like manner. Graphic statistics centered on frequency distribution and percentages and Chi-square test was also conducted. A p-value &lt; 0.05 was reflected as statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Sixty TB suspected patients were included in this study, 43 (71.7%) were male, and 17 (23.3%) were female, 60% were Saudi nationality, and 40% were Non Saudi nationality, ages were ranged between 10 - 70 years old, with the majority range between 25 - 44 years (56.7%), followed by 10 - 24 years (26.7%), and 45 - 70 years (16.7%) as shown in <xref ref-type="table" rid="table1">Table 1</xref>. Our results showed no statistical significance, (p value &gt; 0.05) was detected between the age, sex, and nationality with the presence or absence of TB infection (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Out of 60 patients specimens 35 (58.3%) were positive for MTB, and 25 (41.7%) were negative for MTB culture (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>). Positive M. tuberculosis cultures were affirmed by Real-Time PCR amplification curve, and it created Ct values ranged between 11.5 and 25.5 (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Smear results showed that 29 (48.3%) were AFB positive, and 31 (51.7%) were non AFB (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>). Contrasted with culture as reference method, smear had sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and analytical exactness of 77.14% (95% as a confident interval (CI) 60.98, 87.93&#185;), 92% (95%(CI) 75.03, 97.78&#185;), 93.1% (95% (CI) 78.04, 98.09&#185;), 74.19% (95% (CI) 56.75, 86.3&#185;), 83.33% (95% (CI) 71.97, 90.69&#185;), respectively as shown in (<xref ref-type="table" rid="table3">Table 3</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Amplification plot of isolated M. tuberculosis DNA by IS6110 gene, Ct values ranged between 11.5 - 25.5 (Positive control Ct 25.5, Negative control Ct 37.3)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1130184x4.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Results of ZN smear, IS6110, TB11/12, GeneXpert MTB/RIF assays and culture method</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1130184x5.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Sensitivity and specificity, of ZN smear, IS6110, TB11/12 and GeneXpert MTB/ RIF assays using culture method as reference</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1130184x6.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of the 60 patients, specimens analyzed and culture results</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Age groups</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >10 - 24 years</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >26.7</td></tr><tr><td align="center" valign="middle" >25 - 44 years</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >56.7</td></tr><tr><td align="center" valign="middle" >45 - 70 years</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >16.7</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >71.7</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >28.3</td></tr><tr><td align="center" valign="middle" >Nationality</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Saudi</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >60.0</td></tr><tr><td align="center" valign="middle" >Non-Saudi</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >40.0</td></tr><tr><td align="center" valign="middle" >ZN smear</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >+VE</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >48.3</td></tr><tr><td align="center" valign="middle" >−VE</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >51.7</td></tr><tr><td align="center" valign="middle" >IS6110</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >+VE</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >60.0</td></tr><tr><td align="center" valign="middle" >−VE</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >40.0</td></tr><tr><td align="center" valign="middle" >TB11/12</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >+VE</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >60.0</td></tr><tr><td align="center" valign="middle" >−VE</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >40.0</td></tr><tr><td align="center" valign="middle" >Culture</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >+VE</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >58.3</td></tr><tr><td align="center" valign="middle" >−VE</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41.7</td></tr><tr><td align="center" valign="middle" >Xpert MTB/RIF</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >+VE</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >55.0</td></tr><tr><td align="center" valign="middle" >−VE</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >38.3</td></tr><tr><td align="center" valign="middle" >ND</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >6.7</td></tr></tbody></table></table-wrap><p>+VE(Positive), −VE(Negative), ND(Not done).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of demographic data of the patients and positive results of ZN smear, IS6110, TB11/12 and Xpert MTB/RIF assays with the culture method as reference</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Characteristics</th><th align="center" valign="middle"  colspan="5"  >NO. and% of positive samples</th></tr></thead><tr><td align="center" valign="middle" >ZN smear</td><td align="center" valign="middle" >IS6110</td><td align="center" valign="middle" >TB11/12</td><td align="center" valign="middle" >Xpert MTB/RIF</td><td align="center" valign="middle" >Culture</td></tr><tr><td align="center" valign="middle" >Age groups</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >10 - 24 years</td><td align="center" valign="middle" >9 (56.2)</td><td align="center" valign="middle" >10 (62.5)</td><td align="center" valign="middle" >10 (62.5)</td><td align="center" valign="middle" >9 (60.0)</td><td align="center" valign="middle" >10)62.5)</td></tr><tr><td align="center" valign="middle" >25 - 44 years</td><td align="center" valign="middle" >16 (47.1)</td><td align="center" valign="middle" >21 (61.8)</td><td align="center" valign="middle" >21 (61.8)</td><td align="center" valign="middle" >19 (61.3)</td><td align="center" valign="middle" >21 (61.8)</td></tr><tr><td align="center" valign="middle" >45 - 70 years</td><td align="center" valign="middle" >4 (40.0)</td><td align="center" valign="middle" >5 (50.0)</td><td align="center" valign="middle" >5 (50.0)</td><td align="center" valign="middle" >5 (50.0)</td><td align="center" valign="middle" >4 (40.0)</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >22 (51.2)</td><td align="center" valign="middle" >27 (62.8)</td><td align="center" valign="middle" >27 (62.8)</td><td align="center" valign="middle" >24 (61.5)</td><td align="center" valign="middle" >27 (62.8)</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >7 (41.2)</td><td align="center" valign="middle" >9 (52.9)</td><td align="center" valign="middle" >9 (52.9)</td><td align="center" valign="middle" >9 (52.9)</td><td align="center" valign="middle" >8 (47.1)</td></tr><tr><td align="center" valign="middle" >Nationality</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Saudi</td><td align="center" valign="middle" >15 (41.7)</td><td align="center" valign="middle" >20 (55.6)</td><td align="center" valign="middle" >20 (55.6)</td><td align="center" valign="middle" >18 (54.5)</td><td align="center" valign="middle" >19 (52.8)</td></tr><tr><td align="center" valign="middle" >Non- Saudi</td><td align="center" valign="middle" >14 (58.3)</td><td align="center" valign="middle" >16 (66.7)</td><td align="center" valign="middle" >16 (66.7)</td><td align="center" valign="middle" >15 (65.2)</td><td align="center" valign="middle" >16 (66.7)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29 (48.3)</td><td align="center" valign="middle" >36 (60.0)</td><td align="center" valign="middle" >36 (60.0)</td><td align="center" valign="middle" >33 (58.9)</td><td align="center" valign="middle" >35 (58.3)</td></tr></tbody></table></table-wrap><p>No statistical significance was detected between the specified assay and the culture.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of the ZN smear, IS6110, TB11/12 and Xpert MTB/RIF assay with the culture method as reference</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Specimen type</th><th align="center" valign="middle" >Sensitivity</th><th align="center" valign="middle" >Specificity</th><th align="center" valign="middle" >PPV</th><th align="center" valign="middle" >NPV</th><th align="center" valign="middle" >Diagnostic Accuracy</th></tr></thead><tr><td align="center" valign="middle"  colspan="5"  >No. (%), 95% confidence interval (CI)</td></tr><tr><td align="center" valign="middle" >ZN smear</td><td align="center" valign="middle" >77.14% (60.98, 87.93&#185;)</td><td align="center" valign="middle" >92% (75.03, 97.78&#185;)</td><td align="center" valign="middle" >93.1% (78.04, 98.09&#185;)</td><td align="center" valign="middle" >74.19% (56.75, 86.3&#185;)</td><td align="center" valign="middle" >83.33% (71.97, 90.69&#185;)</td></tr><tr><td align="center" valign="middle" >IS6110</td><td align="center" valign="middle" >100% (90.11, 100&#185;)</td><td align="center" valign="middle" >96% (80.46, 99.29&#185;)</td><td align="center" valign="middle" >97.22% (85.83, 99.51&#185;)</td><td align="center" valign="middle" >100% (86.2, 100&#185;)</td><td align="center" valign="middle" >98.33% (91.14, 99.71&#185;)</td></tr><tr><td align="center" valign="middle" >TB11/12</td><td align="center" valign="middle" >100% (90.11, 100&#185;)</td><td align="center" valign="middle" >96% (80.46, 99.29&#185;)</td><td align="center" valign="middle" >97.22% (85.83, 99.51&#185;)</td><td align="center" valign="middle" >100% (86.2, 100&#185;)</td><td align="center" valign="middle" >98.33% (91.14, 99.71&#185;)</td></tr><tr><td align="center" valign="middle" >Xpert MTB/RIF</td><td align="center" valign="middle" >100% (89.28, 100&#185;)</td><td align="center" valign="middle" >96.97% (79.76, 99.26&#185;)</td><td align="center" valign="middle" >96.97% (84.68, 99.46&#185;)</td><td align="center" valign="middle" >100% (85.69, 100&#185;)</td><td align="center" valign="middle" >98.21% (90.55, 99.68&#185;)</td></tr></tbody></table></table-wrap><p>In the current study, both of IS6110 and Hsp65 (TB11/12) gave similarity in results 36 (60%) were positive for M. tuberculosis DNA, and 24 (40%) were negative (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>). Compared with culture as reference method, both IS6110 and Hsp65 (TB11/12) genes produced same sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of 100% (95% (CI) 90.11, 100&#185;), 96% (95% (CI) 80.46, 99.29&#185;), 97.22% (95% (CI) 85.83, 99.51&#185;), 100% 995% (CI) 86.2, 100&#185;), 98.33% (95% (CI) 91.14, 99.71&#185; ), respectively as shown in (<xref ref-type="table" rid="table3">Table 3</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>In this study Xpert MTB/RIF showed that 33 (55%) out of 56 tested samples were positive for MTB, 23 (38.3%) were negative, and 4 (6.7%) were not done (ND) for the machine factor, as shown in (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>). Compared with culture as reference method, Xpert MTB/RIF gave sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of 100% (95% (CI) 89.28, 100&#185;), 96,97% (95% (CI) 79.76, 99.26&#185;), 96.97% (95% (CI) 84.68, 99.46&#185;), 100% (95% (CI) 85.69, 100&#185;), 98.21% (95% (CI) 90.55, 99.68&#185;), respectively as shown in (<xref ref-type="table" rid="table3">Table 3</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>). Beside MTB detection the test also detected the sensitivity and resistance to Rifampicin, in this study one sample out of 33 (3%) had resistance.</p></sec><sec id="s4"><title>4. Discussion</title><p>The early diagnosis of TB is very important to start early treatment and to establish preventive measures of the disease control [<xref ref-type="bibr" rid="scirp.74002-ref1">1</xref>] . In this study, the diagnostic accuracy of AFB smear, conventional and automated nested PCR was evaluated compared with culture as a gold standard method.</p><p>In this study one patient specimen gave negative result with culture method and positive with molecular methods utilized as a part of this study, this may be due to either by the non-viable bacilli existent in the sample or the small quantity of the bacteria.</p><p>When compared with other molecular tests smear produced the lowest sensitivity, which indicated that smear is still not the suitable method for diagnosing TB, although it is a quick and cheap method for diagnosis. On the other hand, smear could be more efficient when used for treatment monitoring as described before [<xref ref-type="bibr" rid="scirp.74002-ref1">1</xref>] .</p><p>Our findings confirm the diagnostic value of IS6110 and hsp5 genes in rapid detection of pulmonary TB, the same findings were mentioned by Ritis et al. (2000) [<xref ref-type="bibr" rid="scirp.74002-ref22">22</xref>] when he used IS6110 gene, although the sources of the samples were different, and of Maccente et al. (2013) [<xref ref-type="bibr" rid="scirp.74002-ref23">23</xref>] , when she evaluated the hsp65 gene for rapid diagnosis of TB in a high-burden country. Besides the highest diagnostic accuracy of this method, it has many advantages. Firstly, the method is fast, the results can be obtained within one to two working days. Secondly, the method is cheap, it cost about 7 USD. One patient gave a positive result in this method and a negative result by culture, although this sample statistically was calculated as false positive (FP), it could be the occurrence of non-viable bacilli in this sample.</p><p>The Automated Xpert MTB/RIF produced a high diagnostic accuracy for pulmonary TB in sputum samples, our finding was in strong agreement with a study done by Vinod et al. (2014) [<xref ref-type="bibr" rid="scirp.74002-ref24">24</xref>] , although he used samples from Tuberculous meningitis. In our study, one patient sample was positive with Xpert MTP/RIF and negative by culture, the test can detect M. tuberculosis DNA from either nonviable or non-intact bacilli [<xref ref-type="bibr" rid="scirp.74002-ref25">25</xref>] , taking into account also the culture limitation. Many advantages of the Xpert MTB/RIF are, first, it is fast, the result can be obtained within 90 minutes, second, positive result reflect the true detection of M. tuberculosis rather than nontuberculous mycobacteria [<xref ref-type="bibr" rid="scirp.74002-ref25">25</xref>] , third detection of Rifampicin resistant bacteria. Besides all these advantages, the test is expensive, one test cost about 18 USD, which is not suitable for low-income countries.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our results and the diagnostic accuracy that we got from the molecular methods, confirm the diagnostic value of molecular detection of M. tuberculosis in pulmonary cases, supporting the application of automated and conventional PCR in rapid analysis. Combination between one-molecular techniques with smear as a routine method could be valid for rapid diagnosis of TB.</p></sec><sec id="s6"><title>6. Limitations</title><p>Culture result itself can be influenced by numerous elements including sample blunders and other mechanical causes can likewise influence culture sensitivity, which demonstrates our study restrictions.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We gratefully acknowledge the Saudi Basic Industries Corporation (SABIC) K.S.A. for supporting this work (Grant No 2000/S2/36), and Deanship of scientific research at Jazan University Saudi Arabia. We also acknowledge the laboratories of Microbiology at Jazan Chest Diseases Hospital, King Fahad Central Hospital, and Microbiology department at faculty of medicine King Khalid University for their kind technical assistance and collaboration.</p></sec><sec id="s8"><title>Conflict of Interest</title><p>No conflict of interest associated with this work.</p></sec><sec id="s9"><title>Contribution of Authors</title><p>The authors declare that this work was done by the authors named in this article and all liabilities pertaining to claims relating to the content of this article will be borne by them.</p></sec><sec id="s10"><title>Cite this paper</title><p>Abdelhaleem, A.A., Hershan, A.A. and Agarwal, P.K. (2017) Diagnostic Accuracy of IS6110 Insertion Gene, Hsp65, and Xpert MTB/RIF for Rapid Diagnosis of Pulmonary Tuberculosis. Journal of Tuberculosis Research, 5, 1-12. https://doi.org/10.4236/jtr.2017.51001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.74002-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">WHO Report 2015.</mixed-citation></ref><ref id="scirp.74002-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Alhajoj, S.A. (2010) Tuberculosis in Saudi Arabia. Journal of Infection and Public Health, 3, 17-24. https://doi.org/10.1016/j.jiph.2009.12.001</mixed-citation></ref><ref id="scirp.74002-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Varghese, B., Supply, P., Shoukri, M., Allix-Beguec, C., Memish, Z., Abuljadayel, N., Alhakeem, R., Alrabiah, F. and Alhajoj, S. (2013) Tuberculosis Transmission among Immigrants and Autochthonous Populations of the Eastern Province of Saudi Arabia. PLoS ONE, 8, e77635. https://doi.org/10.1371/journal.pone.0077635</mixed-citation></ref><ref id="scirp.74002-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Al-Orainey, I., Alhedaithy, M.A., Alanazi, A.R., Barry, M.A. and Almajid, F.M. (2013) Tuberculosis Incidence Trends in Saudi Arabia over 20 Years: 1991-2010. Annals of Thoracic Medicine, 8, 148-152. https://doi.org/10.4103/1817-1737.114303</mixed-citation></ref><ref id="scirp.74002-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Eisenach, K.D., Cave, M.D. and Crawford, J.T. (1993) PCR Detection of Mycobacterium tuberculosis. In: Persing, D.H., Smith, T.F., Tenover, F.C. and White, T.J., Eds., Diagnostic Molecular Microbiology: Principles and Applications, American Society for Microbiology, Washington DC, 191-196.</mixed-citation></ref><ref id="scirp.74002-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Noordhoek, G.T., Kolk, A.H., Bjune, G., Catty, D., Dale, J.W., Fine, P.E., Godfrey-Faussett, P., Cho, S.N., Shinnick, T., Svenson, S.B., et al. (1994) Sensitivity and Specificity of PCR for Detection of Mycobacterium tuberculosis: A Blind Comparison study among Seven Laboratories. Journal of Clinical Microbiology, 32, 277-284.</mixed-citation></ref><ref id="scirp.74002-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Herrera, E.A., Perez, O. and Segovia, M. (1996) Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by a Multiplex-Polymerase Chain Reaction. Journal of Applied Bacteriology, 80, 596-604.  
https://doi.org/10.1111/j.1365-2672.1996.tb03263.x</mixed-citation></ref><ref id="scirp.74002-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Hellyer, T.J., DesJardin, L.E., Assaf, M.K., et al. (1996) Specificity of IS6110-Based Amplification Assays for Mycobacterium tuberculosis Complex. Journal of Clinical Microbiology, 34, 2843-2846.</mixed-citation></ref><ref id="scirp.74002-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Shawar, R.M., El-Zaatari, F., Nataraj, A. and Clarridge, J.E. (1993) Detection of Mycobacterium tuberculosis by Two-Step Polymerase Chain Reaction and Non Isotopic Hybridization Methods. Journal of Clinical Microbiology, 31, 61-65.</mixed-citation></ref><ref id="scirp.74002-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Folgueira, L., Delgado, R., Palenque, E., Aguado, J.M. and Noriega, A. (1996) Rapid Diagnosis of Mycobacterium tuberculosis Bacteremia by PCR. Journal of Clinical Microbiology, 34, 512-515.</mixed-citation></ref><ref id="scirp.74002-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Akcan, Y., Tuncer, S., Hayran, M., Sungur, A. and Unal, S. (1997) PCR on Disseminated Tuberculosis in Bone Marrow and Liver Biopsy Specimens: Correlation to Histopathological and Clinical Diagnosis. Scandinavian Journal of Infectious Diseases, 29, 271-274. https://doi.org/10.3109/00365549709019041</mixed-citation></ref><ref id="scirp.74002-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Marchetti, G., Gori, A., Catozzi, L., Vago, L., Nebuloni, M., Rossi, M.C., Esposti, A.D., Bandera, A. and Franzetti, F. (1998) Evaluation of PCR in Detection of Mycobacterium tuberculosis from Formalin Fixed, Paraffin-Embedded Tissues: Comparison of Four Amplification Assays. Journal of Clinical Microbiology, 36, 1512-1517.</mixed-citation></ref><ref id="scirp.74002-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Telenti, A., Marchesi, F., Balz, M., Bally, F., Bottger, E.C. and Bodmer, T. (1993) Rapid Identification of Mycobacteria to the Species Level by Polymerase Chain Reaction and Restriction Enzyme Analysis. Journal of Clinical Microbiology, 31, 175-178.</mixed-citation></ref><ref id="scirp.74002-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Van Rie, A., Page-Shipp, L., Scott, L., Sanne, I., Stevens, W. (2010) Xpert&amp;reg; MTB/RIF for Point-of-Care Diagnosis of TB in High-HIV Burden, Resource-Limited Countries: Hype or Hope? Expert Review of Molecular Diagnostics, 10, 937-946.  
https://doi.org/10.1586/erm.10.67</mixed-citation></ref><ref id="scirp.74002-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M.R., Rodgers, R., Banada, P., et al. (2010) Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology. Journal of Clinical Microbiology, 48, 229-237.  
https://doi.org/10.1128/JCM.01463-09</mixed-citation></ref><ref id="scirp.74002-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Boehme, C.C., Nabeta, P., Hillemann, D., Nicol, M.P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. New England Journal of Medicine, 363, 1005-1015. https://doi.org/10.1056/NEJMoa0907847</mixed-citation></ref><ref id="scirp.74002-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kent, P.T. and Kubica, G.P. (1985) Public Health Mycobacteriology: A Guide for the Level III Laboratory. Center for Disease Control, Atlanta.</mixed-citation></ref><ref id="scirp.74002-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Doig, C., Seagar, A.L., Watt, B. and Forbes, K.J. (2002) The Efficacy of the Heat Killing of Mycobacterium tuberculosis. Journal of Clinical Pathology, 55, 778-779.  
https://doi.org/10.1136/jcp.55.10.778</mixed-citation></ref><ref id="scirp.74002-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">El-Dawi, T.G., Saeed, E.S. and Hamid, M.E. (2004) Evaluation of a PCR-Amplified IS6110 in the Rapid Diagnosis of Tuberculosis in Comparison to Smear Method. Saudi Medical Journal, 25, 1644-1647.</mixed-citation></ref><ref id="scirp.74002-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Eisenach, K.D., Cave, M.D., Bates, J.H. and Crawford, J.T. (1990) Polymerase Chain Reaction Amplification of a Repetitive DNA Sequence Specific for Mycobacterium tuberculosis. Journal of Infectious Diseases, 161, 977-981.  
https://doi.org/10.1093/infdis/161.5.977</mixed-citation></ref><ref id="scirp.74002-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Neonakis, I.K., Gitti, Z., Krambovitis, E., and Spandidos, D.A. (2008) Molecular Diagnostic Tools in Mycobacteriology. Journal of Microbiological Methods, 75, 1-11. https://doi.org/10.1016/j.mimet.2008.05.023</mixed-citation></ref><ref id="scirp.74002-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Macente, S., Leite, C., Santos, A., Sequeira, V., Machado, L., Marcodens, N., Herata, M., Herata, R. and Cardoso, R. (2013) Evaluation of Hsp65 Nested PCR-Restriction Analysis (PRA) for Diagnosing of Tuberculosis in High Burden Country. BioMed Research Journal, 2013, Article ID: 391549.</mixed-citation></ref><ref id="scirp.74002-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Ritis, K., Tzoanopoulos, D., Speletas, M., Papadopoulos, E., Arvanitidis, K., Kartali, S. and Sideras, P. (2000) Amplification of IS6110 Sequence for Detection of M. tuberculosis Complex in HIV-Negative Patients with FUO and Evidence of Extra-Pulmonary Disease. Journal of Internal Medicine, 248, 415-424.  
https://doi.org/10.1046/j.1365-2796.2000.00750.x</mixed-citation></ref><ref id="scirp.74002-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Patel, V., Connolly, C., Singh, R., Lenders, L., Matinyenya, B., Theron, G., Ndungu, T. and Dheda, K. (2014) Comparison of Amolicor and GeneXpert MTP/RIF for Diagnosis of Tuberculous Meningitis. Journal of Clinical Microbiology, 52, 3777-3780. https://doi.org/10.1128/JCM.01235-14</mixed-citation></ref><ref id="scirp.74002-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Theron, G., Venter, R., Calligaro, G., Smith, L., Limberis, J., Meldau, R., Chanda, D., Esmail, A., Peter, J. and Dheda, K. (2016) Xpert MTB/RIF Results in Patients with Previous Tuberculosis: Can We Distinguish True from False Positive Results? Clinical Infectious Diseases, 62, 995-1001. https://doi.org/10.1093/cid/civ1223</mixed-citation></ref></ref-list></back></article>